Related Experiment Video
Updated: Jul 15, 2025
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
20.7K
Complement System Inhibitory Drugs in a Zebrafish (Danio rerio) Model: Computational Modeling
Dayanne Carla Fernandes1, Denise V Tambourgi1
1Immunochemistry Laboratory, Butantan Institute, São Paulo 05503-900, Brazil.
International Journal of Molecular Sciences
|September 28, 2023
Summary
Cp40 and PMX205 peptides show promising interactions with zebrafish complement targets. This validates zebrafish as a model for studying complement inhibitors in diseases linked to inflammation.
Area of Science:
- Immunology
- Pharmacology
- Computational Biology
Background:
- Complement system dysregulation causes inflammation and disease.
- Inhibiting complement activation is a therapeutic strategy.
- Cp40 and PMX205 are peptides targeting C3 and C5aR1, respectively.
Purpose of the Study:
- To computationally model interactions between Cp40, PMX205, and their zebrafish targets.
- To validate zebrafish as a model for studying complement inhibitors.
Main Methods:
- In silico molecular docking analysis.
- Computational modeling of peptide-target interactions.
Main Results:
- Cp40 demonstrated positive interactions with its zebrafish target.
- PMX205 showed favorable interactions with its zebrafish target.
- Computational models support the use of zebrafish.
Conclusions:
- Zebrafish can serve as a viable animal model for therapeutic studies involving complement inhibitors.
- Cp40 and PMX205 show potential for targeting the complement system in zebrafish.
- Further in vivo validation is warranted.
